开发一种可解释的机器学习模型,用于复制和解释骨质疏松症治疗中的专家药理学决定
Yutaro Sugawara1, Tomohiro Shimizu2, Hotaka Ishizu2
1Department of Orthopedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan; Department of Orthopedic Surgery, Central Hospital, Hakodate, Hokkaido, Japan.
Bone
|December 3, 2025
概括
可解释的人工智能 (AI) 模型现在可以解释骨质疏松症治疗决策. 腿部部骨矿物质密度和脊椎骨折严重程度是关键因素,增强了对骨质疏松症管理的临床决策支持.
科学领域:
- 人工智能在医学中的应用
- 骨质疏松症管理管理
- 临床决策支持系统 临床决策支持系统
背景情况:
- 骨质疏松症治疗决策是复杂的,在临床实践中存在很大差异.
- 现有的人工智能 (AI) 工具主要支持骨质疏松症诊断,仅限于治疗的逻辑.
- 了解影响治疗选择的因素对于持续有效的患者护理至关重要.
研究的目的:
- 应用可解释的机器学习 (ML) 来复制和解释骨质疏松症的药物治疗决策.
- 确定驱动专家临床医生选择治疗的关键临床因素.
- 评估可解释的人工智能的潜力,以创建透明和可重复的骨质疏松症决策支持工具.
主要方法:
- 在北海道大学医院和附属机构 (2020-2023) 治疗的1481名患者的回顾性分析.
- 两位专家独立地将患者分配到基于双能X射线吸收计 (DXA) 和侧脊椎放射学的五种治疗类别之一.
- 一个LightGBM模型被开发并对372名门诊患者进行外部验证;特征重要性和SHapley添加式扩展 (SHAP) 用于解释.
主要成果:
- 该LightGBM模型实现了高预测性能,准确度为0.90,在外部验证中获得0.90 F1分.
- SHAP分析确定了腿部部骨矿物质密度 (BMD) 和脊椎骨折严重程度 (特别是3级) 是治疗决策中最有影响力的因素.
- 人工智能模型所识别的有影响力的因素与专家临床医生的推理密切相似.
结论:
- 可解释的人工智能可以有效地澄清骨质疏松症治疗决策背后的临床推理.
- 骨矿物质密度和脊椎骨折的严重程度是选择骨质疏松症药物治疗的关键决定因素.
- 这种方法支持开发透明和可重复的人工智能驱动的决策支持工具,以一致地管理骨质疏松症.
相关概念视频
01:20Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
01:26Pharmacokinetic Models: Comparison and Selection Criterion
309
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
309
01:21Mechanistic Models: Overview of Compartment Models
334
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
334
01:31Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
01:12Analysis of Population Pharmacokinetic Data
657
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
657
01:23Mechanistic Models: Compartment Models in Individual and Population Analysis
226
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
226